20780
Butyrylcholine iodide
≥99.0% (AT)
Synonym(s):
(2-Hydroxyethyl)trimethylammonium iodide butyrate
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
CH3CH2CH2COOCH2CH2N(I)(CH3)3
CAS Number:
Molecular Weight:
301.17
Beilstein:
3917649
EC Number:
MDL number:
UNSPSC Code:
12352204
PubChem Substance ID:
NACRES:
NA.83
Quality Level
Assay
≥99.0% (AT)
form
powder
mp
85-89 °C
solubility
methanol: 1 g/10 mL, clear, colorless
storage temp.
2-8°C
SMILES string
[I-].CCCC(=O)OCC[N+](C)(C)C
InChI
1S/C9H20NO2.HI/c1-5-6-9(11)12-8-7-10(2,3)4;/h5-8H2,1-4H3;1H/q+1;/p-1
InChI key
GALNBQVDMJRFGJ-UHFFFAOYSA-M
Looking for similar products? Visit Product Comparison Guide
Other Notes
Substrate for cholinesterase (EC 3.1.1.8); and acetylcholinesterase (EC 3.1.1.7)
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
R D O'Brien et al.
Biochimica et biophysica acta, 526(1), 129-134 (1978-09-11)
Comparisons were made of purified acetylcholinesterase from the heads of wild type house flies with a mutant form (which bound organophosphates and carbamates less tightly). Using 12 substrates and 6 quaternary inhibitors, the only substantial difference was that the Km
D. Nachmansohn et al.
Methods in Enzymology, 1, 642-642 (1955)
Monitoring of air and water for enzyme inhibitors.
L H Goodson et al.
Methods in enzymology, 44, 647-658 (1976-01-01)
Anaïs Barré et al.
Molecules (Basel, Switzerland), 24(7) (2019-04-04)
Despite their side effects, cholinesterase (ChE) inhibitors remain the only approved drugs to treat Alzheimer's disease patients, along with the N-methyl-d-aspartate (NMDA) receptor antagonist memantine. In the last few years, the dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) has also been
Vibhor Gupta et al.
PloS one, 14(11), e0225188-e0225188 (2019-11-26)
Rare diseases defined by genetic mutations are classic targets for gene therapy. More recently, researchers expanded the use of gene therapy in non-clinical studies to infectious diseases through the delivery of vectorized antibodies to well-defined antigens. Here, we further extend
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service